Entering text into the input field will update the search result below

Why Tesla Is Surging While Ford And GM Struggle

Jun. 17, 2020 11:03 AM ETTesla, Inc. (TSLA) StockF, GM730 Comments
Keith Williams profile picture
Keith Williams
8.68K Followers

Summary

  • Tesla surges while legacy manufacturers are struggling to transform.
  • Mindset is critical, Tesla has it while Ford and GM are in survival mode.
  • With mindset comes opportunity, but execution is critical; Tesla is outstanding at execution.
  • GM tries to talk the talk about its battery electric vehicle program, while struggling to survive. Ford is all about its brand, which is built on ICE cars.
  • Tesla shares reach $1000 milestone (bigger market capitalization than Toyota) but COVID-19 isn't done, so caution is needed about investing at this time.

Tesla Cybertruck

Tesla Cybertruck: Source Tesla via The Driven

I've been watching a series of short videos by Andrew Hollo, a Melbourne (Australia) based strategist who has been putting out 5 minute musings on various aspects of how being in lockdown with COVID-19 is impacting him and his clients. I recently watched his episode 9 (Focus during lockdown), which by coincidence followed shortly after I watched an hour long session on Tesla which included an extended interview with Elon Musk. Both videos were fascinating and got me thinking about why Tesla (NASDAQ:NASDAQ:TSLA) is powering on notwithstanding COVID-19 lockdowns, while GM (NYSE:GM) and Ford (NYSE:F) seem to be in survival mode. The numbers are confronting for GM and F, with 1 year stock performance up 361.1% for Tesla, and down 22.1% and 34.9% for GM and Ford respectively. I think there is an interesting story here, which might help investors understand why an investment in Tesla is on my radar, but GM and Ford are evoking sympathy and concern rather than thoughts of investment; so here goes.

We live in challenging times, no better shown than in recent share price movements all over the place. The standout positive result has been Tesla share price closing at $1,025.05 on 10 June (today $990.90). The case can be made that this is all about a qualitative shift in how the market views legacy ICE (Internal Combustion Engine) car makers in comparison with Tesla, which has a narrow focus on electrification (not only of transport but also stationary power markets). This reinforces why the traditional auto companies (and the related infrastructure) are risky investments today. Tesla is not yet bulletproof, but its future is looking stronger than almost at any time in its turbulent history. Tesla was almost alone in the automotive industry in producing a profitable Q1, and the

This article was written by

Keith Williams profile picture
8.68K Followers
Keith began his career as a research scientist (developmental biology, biochemistry, molecular biology) at the Australian National University, University of Oxford (UK), the Max Planck Institute for Biochemistry (Munich, Germany) and finally Macquarie University (Sydney) where he held a Chair in Biology and established the Centre for Analytical Biotechnology. Pioneering the area of proteomics (with Marc Wilkins in his group coining the term), Keith established the world’s first government-funded Major National Proteomics Facility (Australian Proteome Analysis Facility) which was involved with industrialising protein science. Keith left academe with his team to found Proteome Systems Ltd in 1999 to commercialise proteomics. The company had a strong focus on intellectual property, engineering/technology and bioinformatics. As CEO he led the company to ASX listing in 2004. Since 2005 Keith has been involved in new business development in biotech, e-health and other emerging technologies. Keith sees climate change and sustainable development as a major issue for humankind and also a major business disruptor/risk and opportunity. Keith holds a Bachelor Agr Science from the University of Melbourne and a PhD from the Australian National University. He is a Fellow of the Australian Academy of Technological Sciences & Engineering and received an AM (Member of the Order of Australia) for services to the Biotechnology Industry. He has received various industry awards including an Innovation Hero Medal from the Warren Centre for Advanced Engineering. With 300 scientific papers and many patents written, Keith has a clear view of innovation in the Biotechnology and Climate/Renewable Energy space. He is not a financial advisor but his perspective adds relevance to decision-making concerning feasibility and investment in technology innovation.

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About TSLA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on TSLA

Related Stocks

SymbolLast Price% Chg
TSLA
--